SCHEMBL7215472

SCHEMBL7215472

CCCOc1ccccc1CCCOS(C)(=O)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
LTB4R Q15722 1/20 0.43
LTB4R2 Q9NPC1 1/20 0.43
PPARD Q03181 1/20 0.43
ATM Q13315 2/20 0.42
HPGD P15428 1/20 0.42
KDM4E B2RXH2 1/20 0.40
USP2 O75604 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
MMP9 P14780 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
MGLL Q99685 1/20 0.40
CSNK1A1 P48729 1/20 0.39
CSNK1D P48730 1/20 0.39
PRKCD Q05655 1/20 0.39
PAK1 Q13153 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5657713 0.91 L3MBTL1 (0.46) MAPTL3MBTL1NPSR1LTB4RLTB4R2
SCHEMBL6617663 0.90 L3MBTL1 (0.53) MAPTL3MBTL1NPSR1LTB4RLTB4R2
SCHEMBL3175448 0.83 MGLL (0.60) MAPTL3MBTL1MGLL
SCHEMBL3169417 0.82 L3MBTL1 (0.57) L3MBTL1LTB4RLTB4R2PPARDHPGD
SCHEMBL16394966 0.81 KDM4E (0.45) KDM4EUSP2ALDH1A1LMNAMMP9
SCHEMBL24041895 0.81 HTR1A (0.46) MGLL
SCHEMBL5250473 0.81 HTR1A (0.54)
SCHEMBL73826 0.81 CYP1A2 (0.52) MAPTL3MBTL1NPSR1LTB4RLTB4R2
SCHEMBL4860922 0.80 L3MBTL1 (0.56) MAPTL3MBTL1NPSR1ATMHPGD
SCHEMBL9685579 0.80 L3MBTL1 (0.64) MAPTL3MBTL1NPSR1ATMHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627651-B1 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1182195-A1 CYCLIC COMPOUNDS AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed